Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

SELL
$775.18 - $881.7 $1,550 - $1,763
-2 Reduced 50.0%
2 $1,000
Q3 2023

Oct 11, 2023

BUY
$692.45 - $844.37 $2,769 - $3,377
4 New
4 $3,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Perkins Coie Trust CO Portfolio

Follow Perkins Coie Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.